Showing results (41-50 of 57) with videos related to
Sort By:
Pageof 6
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|November 8, 2023
A cohort study of the risk factors and the target AUC to avoid vancomycin-associated acute kidney injury in pediatric patientsNaoko Kanazawa, Akari Shigemi, Nao Amadatsu, et al.Pharmacology Research & Perspectives|February 22, 2021
A novel step-down infusion method of barbiturate therapy: Its safety and effectiveness for intracranial pressure controlYukako Yamakawa, Motohiro Morioka, Tetsuya Negoto, et al.Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|June 2, 2024
Validation and development of population pharmacokinetic model of vancomycin using a real-world database from a nationwide free web applicationKazutaka Oda, Kazuaki Matsumoto, Kensuke Shoji, et al.Basic & Clinical Pharmacology & Toxicology|June 3, 2026
Quantifying the Impact of Discrepancies Between Actual and Recorded Blood Sampling Times on Bayesian Forecasting for Area Under the Concentration-Time Curve Estimation of VancomycinTomoyuki Yamada, Kazutaka Oda, Yoko Hiyama, et al.Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|December 15, 2019
Observational study to determine the optimal dose of daptomycin based on pharmacokinetic/pharmacodynamic analysisTomoyuki Yamada, Yukimasa Ooi, Kazutaka Oda, et al.Pharmaceutics|March 26, 2022
Clinical Practice Guidelines for Therapeutic Drug Monitoring of Vancomycin in the Framework of Model-Informed Precision Dosing: A Consensus Review by the Japanese Society of Chemotherapy and the Japanese Society of Therapeutic Drug MonitoringKazuaki Matsumoto, Kazutaka Oda, Kensuke Shoji, et al.Mycoses|August 16, 2023
Optimal timing for therapeutic drug monitoring of voriconazole to prevent adverse effects in Japanese patientsYuki Hanai, Takashi Ueda, Yukihiro Hamada, et al.Basic & Clinical Pharmacology & Toxicology|April 10, 2016
False Prolongation of Prothrombin Time in the Presence of a High Blood Concentration of DaptomycinTomoyuki Yamada, Ryuji Kato, Kazutaka Oda, et al.British Journal of Clinical Pharmacology|February 17, 2025
Empirical dosage determination of vancomycin for a target area under the concentration-time curve of 400 μg·h/mL in the first 24 h: A prospective multicenter observational study with rich samplingKazutaka Oda, Yoko Hiyama, Takashi Ueda, et al.Acta Neuropathologica Communications|February 25, 2018
Clinical significance of polyglutamylation in primary central nervous system lymphomaNaoki Shinojima, Kenji Fujimoto, Keishi Makino, et al.Pageof 6